Expression profiling of synovial sarcoma by cDNA microarrays: Association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation

American Journal of Pathology

Volumn 161, Issue 5, 2002, Pages 1587-1595

  Allander, Susanne V ^a   Illei, Peter B ^b   Chen, Yidong ^a   Antonescu, Cristina R ^b   Bittner, Mike ^a   Ladanyi, Marc ^b   Meltzer, Paul S ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ONCOPROTEIN; SOMATOMEDIN BINDING PROTEIN 2;

ARTICLE; CELL DIFFERENTIATION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DNA MICROARRAY; DNA SEQUENCE; EPITHELIUM CELL; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE AMPLIFICATION; GENE CNTNAP1; GENE DRPLA; GENE ELF3; GENE ERBB2; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUSION; GENE OLFM1; GENE OVEREXPRESSION; GENE TLE2; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SYNOVIAL SARCOMA;

EID: 0036840271     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64437-9     Document Type: Article

References (68)

1. Lewis JJ, Antonescu CR, Leung DH, Blumberg D, Healey JH, Woodruff JM, Brennan MF: Synovial sarcoma: A multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol 2000, 18:2087-2094
2. Spillane AJ, A'Hern R, Judson IR, Fisher C, Thomas JM: Synovial sarcoma: A clinicopathologic, staging, and prognostic assessment. J Clin Oncol 2000, 18:3794-3803
3. Trassard M, Le DV, Hacene K, Terrier P, Ranchere D, Guillou L, Fiche M, Collin F, Vilain MO, Bertrand G, Jacquemier J, Sastre-Garau X, Bui NB, Bonichon F, Coindre JM: Prognostic factors in localized primary synovial sarcoma: A multicenter study of 128 adult patients. J Clin Oncol 2001, 19:525-534
4. Rosen G, Forscher C, Lowenbraun S, Eilber F, Eckardt J, Holmes C, Fu YS: Synovial sarcoma: Uniform response of metastases to high dose ifosfamide. Cancer 1994, 73:2506-2511
5. Clark J, Rocques PJ, Crew AJ, Gill S, Shipley J, Chan AML, Gusterson BA, Cooper CS: Identification of novel genes, SYT and SSX, involved in t(X;18)(p112;q112) translocation found in human synovial sarcoma. Nat Genet 1994, 7:502-508
6. De Leeuw B, Balemans M, Olde Weghuis D, Geurts van Kessel A: Identification of two alternative fusion genes, SYT-SSX1 and SYT-SSX2, in t(X;18)(p112;q112)-positive synovial sarcomas. Hum Mol Genet 1995, 4:1097-1099
7. Crew AJ, Clark J, Fisher C, Gill S, Grimer R, Chand A, Shipley J, Gusterson BA, Cooper CS: Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J 1995, 14:2333-2340
8. Skytting B, Nilsson G, Brodin B, Xie YT, Lundeberg J, Uhlen M, Larsson O: A novel fusion gene, SYT-SSX4, in synovial sarcoma. J Natl Cancer Inst 1999, 91:974-975
9. Ladanyi M, Bridge JA: Contribution of molecular genetic data to the classification of sarcomas. Hum Pathol 2000, 31:532-538
10. dos Santos NR, de Bruijn DR, Geurts van Kesser A: Molecular mechanisms underlying human synovial sarcoma development. Genes Chromosom Cancer 2001, 30:1-14
11. Ladanyi M: Fusions of the SYT and SSX genes in synovial sarcoma. Oncogene 2001, 20:5755-5762
12. Kato H, Tjernberg A, Zhang W, Krutchinsky A, An W, Takeuchi T, Ohtsuki Y, Sugano S, Chait B, Roeder RG: SYT associates with human SNF/SW1 complexes and the C-terminal region of its fusion partner SSX1 targets histones. J Biol Chem 2002, 277:5498-5505
13. Hiraga H, Nojima T, Abe S, Sawa H, Yamashiro K, Yamawaki S, Kaneda K, Nagashima K: Diagnosis of synovial sarcoma with reverse transcriptase-polymerase chain reaction: Analyses of 84 soft tissue and bone tumors. Diagn Mol Pathol 1998, 7:102-110
14. Birdsall S, Osin P, Lu YJ, Fisher C, Shipley J: Synovial sarcoma specific translocation is associated with both epithelial and spindle cell components. Int J Cancer 1999, 82:605-608
15. Kasai T, Shimajiri S, Hashimoto H: Detection of SYT-SSX fusion transcripts in both epithelial and spindle cell areas of biphasic synovial sarcoma using laser capture microdissection. Mol Pathol 2000, 53: 107-110
16. Noguchi SI, Ueki T, Kawauchi S, Fukuda T, Matsuura H, Sonoda T, Tsuneyoshi M: Establishment and characterization of a new synovial sarcoma cell line, SN-SY-1: Special reference to bcl-2 protein and SYT-SSX1 hybrid transcripts. Int J Cancer 1997, 72:995-1002
17. Yakushiji T, Yonemura K, Tsuruta J, Nishida K, Kato T, Takagi K: Capacity for epithelial differentiation in synovial sarcoma: Analysis of a new human cell line. J Clin Pathol 2000, 53:525-531
18. Noguera R, Navarro S, Cremades A, Rosello-Sastre E, Pellin A, Peydro-Olaya A, Llombart-Bosch A: Translocation (X;18) in a biphasic synovial sarcoma with morphologic features of neural differentiation. Diagn Mol Pathol 1998, 7:16-23
19. Kawai A, Woodruff J, Healey JH, Brennan MF, Antonescu CR, Ladanyi M: SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med 1998, 338:153-160
20. Roberts WM, Douglass EC, Peiper SC, Houghton PJ, Look AT: Amplification of the gli gene in childhood sarcomas. Cancer Res 1989, 49:5407-5413
21. De Risi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM: Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 1996, 14:457-460
22. Khan J, Simon R, Bittner M, Chen Y, Leighton SB, Pohida T, Smith PD, Jiang Y, Gooden GC, Trent JM, Meltzer PS: Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res 1998, 58:5009-5013
23. Khan J, Wei J, Ringnér M, Saal LH, Ladanyi M, Westermann F, Berthold F, Schwab M, Antonescu CR, Peterson C, Meltzer PS: Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 2001, 7:673-679
24. Chen Y, Dougherty ER, Bittner M: Ratio-based decisions and the quantitative analysis of cDNA microarray images. Biomed Opt 1997, 2:364-374
25. Bittner M, Meltzer P, Trent J: Data analysis and integration: Of steps and arrows. Nat Genet 1999, 22:213-215
26. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, Radmacher M, Simon R, Yakhini Z, Ben-Dor A, Sampas N, Dougherty E, Wang E, Marincola F, Gooden C, Lueders J, Glatfelter A, Pollock P, Carpten J, Gillanders E, Leja D, Dietrich K, Beaudry C, Berens M, Alberts D, Sondak V, Hayward N, Trent J: Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000, 406:536-540
27. Hoos A, Stojadinovic A, Mastorides S, Urist MJ, Polsky D, Di Como CJ, Brennan MF, Cordon-Cardo C: High Ki-67 proliferative index predicts disease specific survival in patients with high-risk soft tissue sarcomas. Cancer 2001, 92:869-874
28. Barembaum M, Moreno TA, LaBonne C, Sechrist J, Bronner-Fraser M: Noelin-1 is a secreted glycoprotein involved in generation of the neural crest. Nat Cell Biol 2000, 2:219-225
29. Grbavec D, Lo R, Liu Y, Stifani S: Transducin-like Enhancer of split 2, a mammalian homologue of Drosophila Groucho, acts as a transcriptional repressor, interacts with Hairy/Enhancer of split proteins, and is expressed during neuronal development. Eur J Biochem 1998, 258: 339-349
30. Rios JC, Melendez-Vasquez CV, Einheber S, Lustig M, Grumet M, Hemperly J, Peles E, Salzer JL: Contactin-associated protein (Caspr) and contactin form a complex that is targeted to the paranodal junctions during myelination. J Neurosci 2000, 20:8354-8364
31. Knight SP, Richardson MM, Osmand AP, Stakkestad A, Potter NT: Expression and distribution of the dentatorubral-pallidoluysian atrophy gene product (atrophin-1/drplap) in neuronal and non-neuronal tissues. J Neurol Sci 1997, 146:19-26
32. van Baren N, Chambost H, Ferrant A, Michaux L, Ikeda H, Millard I, Olive D, Boon T, Coulie PG: PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells. Br J Haematol 1998, 102:1376-1379
33. Antonescu CR, Kawai A, Leung DH, Lonardo F, Woodruff JM, Healey JH, Ladanyi M: Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma. Diagn Mol Pathol 2000, 9:1-8
34. Ladanyi M, Antonescu CR, Leung DH, Woodruff JM, Kawai A, Healey JH, Brennan MF, Bridge JA, Neff JR, Barr FG, Goldsmith JD, Brooks JSJ, Goldblum JR, Ali SZ, Shipley JM, Cooper CS, Fisher C, Skytting B, Larsson O: Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma. A multi-institutional retrospective study of 243 patients. Cancer Res 2002, 62:135-140
35. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES: Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 1999, 286: 531-537
36. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson JJ, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Staudt LM: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511
37. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D: Molecular portraits of human breast tumours. Nature 2000, 406:747-752
38. Werner H, Le Roith D: New concepts in regulation and function of the insulin-like growth factors: Implications for understanding normal growth and neoplasia. Cell Mol Life Sci 2000, 57:932-942
39. Khan J, Bittner ML, Saal LH, Teichmann U, Azorsa DO, Gooden GC, Pavan WJ, Trent JM, Meltzer PS: Cdna microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc Natl Acad Sci USA 1999, 96:13264-13269
40. Wang W, Kumar P, Wang W, Epstein J, Helman L, Moore JV, Kumar S: Insulin-like growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma. Cancer Res 1998, 58:4426-4433
41. Xie Y, Skytting B, Nilsson G, Brodin B, Larsson O: Expression of insulin-like growth factor-1 receptor in synovial sarcoma: Association with an aggressive phenotype. Cancer Res 1999, 59:3588-3591
42. Scotlandi K, Benini S, Sarti M, Serra M, Lollini PL, Maurici D, Picci P, Manara MC, Baldini N: Insulin-like growth factor I receptor-mediated circuit in Ewing's sarcoma/peripheral neuroectodermal tumor: A possible therapeutic target. Cancer Res 1996, 56:4570-4574
43. Toretsky JA, Kalebic T, Blakesley V, LeRoith D, Helman LJ: The insulin-like growth factor-I receptor is required for EWS/FLI-1 transformation of fibroblasts. J Biol Chem 1997, 272:30822-30827
44. Hoeflich A, Reisinger R, Lahm H, Kiess W, Blum WF, Kolb HJ, Weber MM, Wolf E: Insulin-like growth factor-binding protein 2 in tumorigenesis: Protector or promoter? Cancer Res 2001, 61:8601-8610
45. Streck RD, Wood TL, Hsu MS, Pintar JE: Insulin-like growth factor I and II and insulin-like growth factor binding protein-2 RNAs are expressed in adjacent tissues within rat embryonic and fetal limbs. Dev Biol 1992, 151:586-596
46. Roholl PJ, Skottner A, Prinsen I, Lips CJ, Den Otter W, Van Unnik JA: Expression of insulin-like growth factor 1 in sarcomas. Histopathology 1990, 16:455-460
47. Bubendorf L, Kolmer M, Kononen J, Koivisto P, Mousses S, Chen Y, Mahlamaki E, Schraml P, Moch H, Willi N, Elkahloun AG, Pretlow TG, Gasser TC, Mihatsch MJ, Sauter G, Kallionlemi OP: Hormone therapy failure in human prostate cancer: Analysis by complementary DNA and tissue microarrays. J Natl Cancer Inst 1999, 91:1758-1764
48. Fuller GN, Rhee CH, Hess KR, Caskey LS, Wang R, Bruner JM, Yung WK, Zhang W: Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: A revelation by parallel gene expression profiling. Cancer Res 1999, 59:4228-4232
49. Sallinen SL, Sallinen PK, Haapasalo HK, Helin HJ, Helen PT, Schraml P, Kallioniemi OP, Kononen J: Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res 2000, 60:6617-6622
50. Menouny M, Binoux M, Babajko S: IGFBP-2 expression in a human cell line is associated with increased IGFBP-3 proteolysis, decreased IGFBP-1 expression and increased tumorigenicity. Int J Cancer 1998, 77:874-879
51. Renehan AG, Painter JE, O'Halloran D, Atkin WS, Potten CS, O'Dwyer ST, Shalet SM: Circulating insulin-like growth factor II and colorectal adenomas. J Clin Endocrinol Metab 2000, 85:3402-3408
52. Wex H, Vorwerk P, Mohnike K, Bretschneider D, Kluba U, Aumann V, Blum WF, Mittler U: Elevated serum levels of IGFBP-2 found in children suffering from acute leukaemia is accompanied by the occurrence of IGFBP-2 mRNA in the tumour clone. Br J Cancer 1998, 78:515-520
53. Duda RB, Cundiff D, August CZ, Wagman LD, Bauer KD: Growth factor receptor and related oncogene determination in mesenchymal tumors. Cancer 1993, 71:3526-3530
54. George E, Niehans GA, Swanson PE, Strickler JG, Singleton TP: Overexpression of the c-erbB-2 oncogene in sarcomas and small round-cell tumors of childhood. An immunohistochemical investigation. Arch Pathol Lab Med 1992, 116:1033-1035
55. Harari D, Yarden Y: Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. Oncogene 2000, 19:6102-6114
56. Kuhnen C, Tolnay E, Steinau HU, Voss B, Muller KM: Expression of c-Met receptor and hepatocyte growth factor/scatter factor in synovial sarcoma and epithelioid sarcoma. Virchows Arch 1998, 432:337-342
57. Yang Y, Spitzer E, Meyer D, Sachs M, Niemann C, Hartmann G, Weidner KM, Birchmeier C, Birchmeier W: Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J Cell Biol 1995, 131:215-226
58. Castagnino P, Lorenzi MV, Yeh J, Breckenridge D, Sakata H, Munz B, Werner S, Bottaro DP: Neu differentiation factor/heregulin induction by hepatocyte and keratinocyte growth factors. Oncogene 2000, 19:640-648
59. Zhou BP, Liao Y, Xia W, Zou Y, Spohn B, Hung MC: HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol 2001, 3:973-982
60. Tamborini E, Papini D, Mezzelani A, Riva C, Azzarelli A, Sozzi G, Pierotti MA, Pilotti S: C-KIT and c-KIT ligand (SCF) in synovial sarcoma (SS): An mRNA expression analysis in 23 cases. Br J Cancer 2001, 85:405-411
61. Miettinen M, Limon J, Niezabitowski A, Lasota J: Patterns of keratin polypeptides in 110 biphasic, monophasic, and poorly differentiated synovial sarcomas. Virchows Arch 2000, 437:275-283
62. Oettgen P, Alani RM, Barcinski MA, Brown L, Akbarali Y, Boltax J, Kunsch C, Munger K, Libermann TA: Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family. Mol Cell Biol 1997, 17:4419-4433
63. Thomas RS, Ng AN, Zhou J, Tymms MJ, Doppler W, Kola I: The Elf group of Ets-related transcription factors. ELF3 and ELF5. Adv Exp Med Biol 2000, 480:123-128
64. Chang CH, Scott GK, Kuo WL, Xiong X, Suzdaltseva Y, Park JW, Sayre P, Erny K, Collins C, Gray JW, Benz CC: ESX: A structurally unique Ets overexpressed early during human breast tumorigenesis. Oncogene 1997, 14:1617-1622
65. Neve RM, Ylstra B, Chang CH, Albertson DG, Benz CC: ErbB2 activation of ESX gene expression. Oncogene 2002, 21:3934-3938
66. Saito T, Oda Y, Sugimachi K, Kawaguchi KK, Tamiya S, Tanaka K, Matsuda S, Sakamoto A, Iwamoto Y, Tsuneyoshi M: E-cadherin gene mutations frequently occur in synovial sarcoma as a determinant of histological features. Am J Pathol 2001, 159:2117-2124
67. Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD, Sallan SE, Lander ES, Golub TR, Korsmeyer SJ: MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002, 30:41-47
68. Nielsen TO, West RB, Linn SC, Alter O, Knowling MA, O'Connell JX, Zhu S, Fero M, Sherlock G, Pollack JR, Brown PO, Botstein D, van de Rijn M: Molecular characterisation of soft tissue tumours: A gene expression study. Lancet 2002, 359:1301-1307